ARTV: artivabio.com Kompaniya qiymatining sof foydaga nisbati

Artiva Biotherapeutics - ARTV emitenti grafik logotipi

Ushbu grafikda -2.00 indikatori bilan ko'rsatilgan Artiva Biotherapeutics, Inc. (ARTV) bozor narxi biologik preparatlar uchun ilg'or ommaviy ishlab chiqarish texnologiyalaridan foydalanish va global farmatsevtika kompaniyalari bilan ittifoqlar asosida shakllanmoqda. O'simtalarni davolash uchun tayyor NK hujayralarini ishlab chiqish hozirda yirik chiqishlar oldidan o'zining eng yuqori samaradorlik bosqichida turibdi. Biroq, biznes klinik sinovlarning ilk bosqichlarida yuqori ishlab chiqarish xarajatlari va tashqi moliyalashtirishga bog'liqlik muammolariga duch kelmoqda.

Narx-foyda koeffitsiyenti: Artiva (ARTV) 26.03.2025 - 18.11.2026 uchun

Artiva Biotherapeutics Inc. (ARTV) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning jamlanma tahlili:ARTV, Artiva Biotherapeutics Inc.
Artiva Biotherapeutics yetakchi tovari

P/E koeffitsiyenti biznesning bozor qiymatini uning foydasiga nisbatan o'lchaydi va moliyaviy hisobotlar e'lon qilinishidan oldin talab muvozanatining buzilishi orqali likvidlik risklari va qarz xizmati xarajatlarining real vaqt rejimida bahosini taqdim etadi. Artiva Biotherapeutics, Inc. (ARTV) kompaniyasining P/E tarixini tahlil qilish orqali investor uning kapitalizatsiyasi barqarorligini baholashi mumkin, bunda yuqori aktiv qiymatlari asosiy NK-hujayra terapiyasi ishlab chiquvchilarining strategik saqlanishi va biomanufakturing mutaxassislarining jalb qilinishi bilan ta'minlanadi.

Raqobatdosh kompaniyalar tahlili

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori AURA|Narx-foyda koeffitsiyenti Candel Therapeutics, Inc. CADL|P/E multiplikatori ARAY (Accuray, Inc.)|SELLAS Life Sciences - Narxning foydaga nisbati|ACTU: Narx-foyda koeffitsiyenti|Citius Oncology, Inc. - Bozor narxining sof foydaga nisbati|HURA (TuHURA Biosciences) - Narx-foyda koeffitsiyenti|TARA: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti FATE|WHWK: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TCRX (TScan Therapeutics Inc)|Biznesning o‘zini qoplash muddati Champions Oncology Inc|P/E multiplikatori XBIT (XBiotech Inc.)|Kompaniya qiymatining sof foydaga nisbati CVM|OS Therapies Inc. - P/E multiplikatori|RADX - P/E multiplikatori|ANL (adlainortye.com) - Narx-foyda koeffitsiyenti|VERU - Biznesning o‘zini qoplash muddati|TPST (Tempest Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori xiliotx.com|Narxning foydaga nisbati Enochian BioSciences (RENB)|Narxning foydaga nisbati MURA (Mural Oncology PLC)|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV